Page last updated: 2024-12-06

alpha-tocopherol succinate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Alpha-tocopherol succinate (ATS) is a synthetic derivative of vitamin E, specifically alpha-tocopherol. It is produced by reacting alpha-tocopherol with succinic anhydride. ATS exhibits enhanced bioavailability and stability compared to alpha-tocopherol. Research suggests that ATS possesses antioxidant properties, potentially protecting cells from damage caused by free radicals. Studies have investigated its potential benefits in various conditions, including cardiovascular disease, neurodegenerative disorders, and cancer. The enhanced bioavailability and stability of ATS make it a promising candidate for therapeutic applications.'
```

Cross-References

ID SourceID
PubMed CID20353
CHEMBL ID81421
CHEBI ID135821
SCHEMBL ID134422
MeSH IDM0104481

Synonyms (116)

Synonym
CHEMBL81421
alpha-tocopherol, succinate
alpha-tocopheryl hydrogen succinate
alpha-tocopheryl succinate, d-
einecs 224-403-8
mono(3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2h-1-benzopyran-6-yl) butanedioate, (2r-(2r*(4r*,8r*)))-
ccris 4734
2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-6-chromanyl hydrogen succinate, (+)-
mono(2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-6-chromanyl) succinate, (+)-
d-alpha-tocopherol acid succinate
butanedioic acid, mono((2r)-3,4-dihydro-2,5,7,8-tetramethyl-2-((4r,8r)-4,8,12-trimethyltridecyl)-2h-1-benzopyran-6-yl) ester
alpha-tocopherol hemisuccinate
vitamin e hemisuccinate
alpha-tocopherol acid succinate, d-
alpha-tocopheryl acid succinate
tocopherol acid succinate, alpha-
butanedioic acid, mono(3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2h-1-benzopyran-6-yl) ester, (2r-(2r*(4r*,8r*)))-
dal-e
C033716
alpha-tocopherol succinate
tocopherol succinate
wiedemann brand of vitamin e succinate
vitamin-e dragees
alpha tocopheryl acid succinate
dal-vita brand of vitamin e succinate
55134-51-5
vitamin e succinate
4-oxo-4-[(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]chroman-6-yl]oxy-butanoic acid
butanedioic acid, mono[(2r)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-2h-1-benzopyran-6-yl] ester
.alpha.-tocopherol succinate
d-alpha-tocopherol succinate, semisynthetic, 1210 iu/g
d-alpha-tocopherol succinate, analytical standard
4345-03-3
alpha-tocopheryl succinate
d-alpha-tocopheryl succinate
mono((2r)-3,4-dihydro-2,5,7,8-tetramethyl-2-((4r,8r)-4,8,12-trimethyltridecyl)-2h-1-benzopyran-6-yl) butanedioate
NCGC00167561-01
d-alpha-tocopherol succinate, bioxtra, >=98.0% (hplc)
CHEBI:135821
4-oxo-4-[[(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid
D08612
white-e [veterinary] (tn)
NCGC00167561-02
einecs 241-433-7
(3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2h-1-benzopyran-6-yl) hydrogen succinate
3-{[(2r)-2-((4r,8r)-4,8,12-trimethyltridecyl)-2,5,7,8-tetramethylchroman-6-yl] oxycarbonyl}propanoic acid
tox21_112556
dtxsid2026151 ,
cas-4345-03-3
tox21_200568
NCGC00258122-01
dtxcid706151
lu4b53jyve ,
(+)-alpha-tocopheryl succinate
alpha-vitamin e succinate
cv 104
covitol 1210
butanedioic acid, 1-((2r)-3,4-dihydro-2,5,7,8-tetramethyl-2-((4r,8r)-4,8,12-trimethyltridecyl)-2h-1-benzopyran-6-yl) ester
unii-lu4b53jyve
alpha-tocopherol, succinate, d-
alpha-tocopherol succinate, d-
d-|a-tocopherol succinate
|a-tocopheryl succinate
AKOS015902063
d-alpha-tocopherol succinate
rrr-alpha-tocopheryl acid succinate
j24.824j ,
tocopheryl acid succinate [vandf]
.alpha.-tocopheryl succinate, d-
vitamin e (alpha-tocopheryl succinate)
rrr-.alpha.-tocopheryl hydrogen succinate
.alpha.-tocopheryl succinate
tocopheryl acid succinate, d-alpha
d-alpha tocoferil acid succinate [mart.]
.alpha.-tocopherol succinate [mi]
rrr-alpha-tocopheryl acid succinate [fcc]
tocopheryl succinate
rrr-.alpha.-tocopheryl hydrogen succinate [ep impurity]
.alpha.-tocopherol succinate, d-
tocopheryl succinate [inci]
tocopheryl acid succinate,d-alpha [vandf]
tocopheryl acid succinate [who-dd]
CCG-207945
SCHEMBL134422
NCGC00167561-03
tocopheryl acid succinate,d-alpha
(+)-.alpha.-tocopherol acid succinate
T2628
mfcd00072055
AC-1132
SR-01000883728-1
sr-01000883728
alpha tocopheryl acid succinate, united states pharmacopeia (usp) reference standard
4-oxo-4-{[(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydro-2h-1-benzopyran-6-yl]oxy}butanoic acid
AS-75106
tocopheryl acid succinate, a, pharmaceutical secondary standard; certified reference material
rrr-alpha-tocopheryl hydrogen succinate, european pharmacopoeia (ep) reference standard
4-oxo-4-((r)-2,5,7,8-tetramethyl-2-((4r,8r)-4,8,12-trimethyltridecyl)chroman-6-yloxy)butanoic acid
dl-alpha-tocopherolhydrogensuccinate
DB14001
d-alpha-tocopheryl-succinate
C90299
Q27283185
4-oxo-4-(((r)-2,5,7,8-tetramethyl-2-((4r,8r)-4,8,12-trimethyltridecyl)chroman-6-yl)oxy)butanoic acid
butanedioic acid,mono[(2r)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-2h-1-benzopyran-6-yl] ester
bdbm50458511
d-alpha-tocopherolsuccinate
4-oxo-4-(((r)-2,5,7,8-tetramethyl-2-((4r,8r)-4,8,12-trimethyltridecyl)chroman-6-yl)oxy)butanoicacid
EN300-23011947
rrr-alpha-tocopheryl hydrogen succinate
rrr-alpha-tocopheryl hydrogen succinate; (2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydro-2h-1-benzopyran-6-yl hydrogen succinate; d-alpha-tocopherol succinate; vitamin e succinate; (+)-alpha-tocopheryl acid succinate; d-alpha-toc
d-alpha-tocopheryl hydrogen succinate
CS-0136520
HY-131553
d- alpha -tocopheryl succinate
Z2216889767

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (18 Product(s))

Product Categories

Product CategoryProducts
Active Lifestyle & Fitness13
Food & Beverages1
Vitamins & Supplements3
Weight Management1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Greens Plus +plusbar Protein Chocolate -- 12 BarsGreens PlusActive Lifestyle & Fitnessd-alpha tocopheryl succinate, beta-carotene, Biotin, vitamin d3, vitamin e, vitamin e, Pantothenic Acid, Vitamin B6, vitamin a, Riboflavin, Thiamin, Vitamin B12, Vitamin B62024-11-29 10:47:42
Greens Plus Dairy Free Plusbar Energy Chocolate -- 12 BarsGreens PlusFood & BeveragesD-Alpha tocopheryl succinate, beta-carotene, Biotin, vitamin D3, vitamin E, vitamin E, Pantothenic Acid, Vitamin B6, vitamin A, Riboflavin, Thiamin, Vitamin B12, Vitamin B62024-11-29 10:47:42
Life Extension Two-Per-Day Capsules -- 120 CapsulesLife ExtensionVitamins & SupplementsD-alpha tocopheryl succinate, Apigenin, Vitamin C, Biotin, Boron, dicalcium phosphate, Vitamin D3, Vitamin E, riboflavin 5'-phosphate, Folate, Vitamin E, gluconate, Inositol, Iodine, maltodextrin, Manganese, Molybdenum, Niacin, niacinamide, Pantothenic Acid, pyridoxal 5'-phosphate, pyridoxine HCl, Vitamin B6, Vitamin A, Riboflavin, Thiamine, Alpha-Lipoic Acid, beta, Vitamin B12, Vitamin B62024-11-29 10:47:42
Life Extension Two-Per-Day Tablets -- 120 TabletsLife ExtensionVitamins & SupplementsD-alpha tocopheryl succinate, Apigenin, Vitamin C, Biotin, Boron, dicalcium phosphate, Vitamin D3, Vitamin E, riboflavin 5'-phosphate, Folate, Vitamin E, gluconate, glycerin, Microcrystalline cellulose, Inositol, Iodine, maltodextrin, Manganese, Molybdenum, Niacin, niacinamide, Pantothenic Acid, pyridoxal 5'-phosphate, pyridoxine HCI, Vitamin B6, Vitamin A, Riboflavin, stearic acid, Thiamine, Alpha-Lipoic Acid, beta, Vitamin B12, Vitamin B62024-11-29 10:47:42
Naturade Total Soy® Meal Replacement Strawberry Creme -- 17.88 ozNaturadeWeight Managementd-alpha tocopheryl succinate, Vitamin C, beta carotene, Biotin, calcium pantothenate, Vitamin D3, Chromium, Vitamin E, Fructose, ferrous sulfate, Folate, Vitamin E, Iodine, maltodextrin, Manganese, Niacin, niacinamide, Pantothenic Acid, Phosphorus, potassium chloride, Vitamin B6, Vitamin A, Riboflavin, Selenium, Thiamin, cyanocobalamin, Vitamin B62024-11-29 10:47:42
Optimum Nutrition Serious Mass Protein Powder Supplement Chocolate -- 16 ServingsOptimum NutritionActive Lifestyle & FitnessPABA, acesulfame potassium, acesulfame potassium, d-alpha tocopheryl succinate, Vitamin C, beta carotene, Biotin, calcium citrate, d-calcium pantothenate, di-calcium phosphate, cholecalciferol, Choline, Chromium, copper gluconate, Vitamin E, ferrous fumarate, folic acid, Vitamin E, L-Glutamine, Inositol, Iodine, Maltodextrin, Manganese, Molybdenum, Niacin, niacinamide, PABA, Pantothenic Acid, Phosphorus, potassium iodide, pyridoxine hydrochloride, Vitamin B6, Vitamin A, Riboflavin, Selenium, selenomethionine, Thiamin, cyanocobalamin, Vitamin B62024-11-29 10:47:42
TransformHQ Meal Replacement Shake - 28 Servings Chocolate -- 2.6 lbsTransformHQActive Lifestyle & Fitnessd-alpha tocopheryl succinate, D-calcium pantothenate, vitamin D3, Vitamin E, Folate, vitamin E, Niacin, niacinamide, Pantothenic Acid, pyridoxine HCI, Vitamin B6, vitamin B2, Thiamin, vitamin B1, sucralose, vitamin B12, vitamin B62024-11-29 10:47:42
TransformHQ Meal Replacement Shake - 28 Servings Chocolate Peanut Butter -- 2.5 lbsTransformHQActive Lifestyle & Fitnessd-alpha tocopheryl succinate, D-calcium pantothenate, vitamin D3, Vitamin E, Folate, vitamin E, Niacin, niacinamide, Pantothenic Acid, Phosphorus, pyridoxine HCI, Vitamin B6, vitamin B2, Thiamin, sucralose, vitamin B12, vitamin B62024-11-29 10:47:42
TransformHQ Meal Replacement Shake - 28 Servings Cookies & Cream -- 2.7 lbsTransformHQActive Lifestyle & Fitnessd-alpha tocopheryl succinate, D-calcium pantothenate, vitamin D3, vitamin E, Folate, vitamin E, Niacin, niacinamide, Pantothenic Acid, Phosphorus, pyridoxine HCI, Vitamin B6, vitamin B2, Thiamin, sucralose, vitamin B12, vitamin B62024-11-29 10:47:42
TransformHQ Meal Replacement Shake - 28 Servings Orange Cream -- 2.5 lbsTransformHQActive Lifestyle & Fitnessd-alpha tocopheryl succinate, D-calcium pantothenate, vitamin D3, Vitamin E, Folate, vitamin E, Niacin, niacinamide, Pantothenic Acid, Phosphorus, pyridoxine HCI, Vitamin B6, vitamin B2, Thiamin, sucralose, vitamin B12, vitamin B62024-11-29 10:47:42
TransformHQ Meal Replacement Shake - 28 Servings Strawberries & Cream -- 2.5 lbsTransformHQActive Lifestyle & Fitnessd-alpha tocopheryl succinate, D-calcium pantothenate, vitamin D3, vitamin E, Folate, vitamin E, Niacin, niacinamide, Pantothenic Acid, Phosphorus, pyridoxine HCI, Vitamin B6, vitamin B2, Thiamin, sucralose, vitamin B12, vitamin B62024-11-29 10:47:42
TransformHQ Meal Replacement Shake - 28 Servings Vanilla -- 2.5 lbsTransformHQActive Lifestyle & Fitnessd-alpha tocopheryl succinate, D-calcium pantothenate, vitamin D3, Vitamin E, Folate, vitamin E, Niacin, niacinamide, Pantothenic Acid, pyridoxine HCI, Vitamin B6, vitamin B2, Thiamin, vitamin B1, sucralose, vitamin B12, vitamin B62024-11-29 10:47:42
TransformHQ Meal Replacement Shake - 7 Servings Chocolate -- 10.5 ozTransformHQActive Lifestyle & Fitnessd-alpha tocopheryl succinate, D-calcium pantothenate, vitamin D3, Vitamin E, Folate, vitamin E, Niacin, niacinamide, Pantothenic Acid, pyridoxine HCI, Vitamin B6, vitamin B2, Thiamin, vitamin B1, sucralose, vitamin B12, vitamin B62024-11-29 10:47:42
TransformHQ Meal Replacement Shake - 7 Servings Chocolate Peanut Butter -- 10.1 ozTransformHQActive Lifestyle & Fitnessd-alpha tocopheryl succinate, D-calcium pantothenate, vitamin D3, Vitamin E, Folate, vitamin E, Niacin, niacinamide, Pantothenic Acid, Phosphorus, pyridoxine HCI, Vitamin B6, vitamin B2, Thiamin, sucralose, vitamin B12, vitamin B62024-11-29 10:47:42
TransformHQ Meal Replacement Shake - 7 Servings Cookies & Cream -- 11.1 ozTransformHQActive Lifestyle & Fitnessd-alpha tocopheryl succinate, D-calcium pantothenate, vitamin D3, vitamin E, Folate, vitamin E, Niacin, niacinamide, Pantothenic Acid, Phosphorus, pyridoxine HCI, Vitamin B6, vitamin B2, Thiamin, sucralose, vitamin B12, vitamin B62024-11-29 10:47:42
TransformHQ Meal Replacement Shake - 7 Servings Strawberries & Cream -- 10.1 ozTransformHQActive Lifestyle & Fitnessd-alpha tocopheryl succinate, D-calcium pantothenate, vitamin D3, vitamin E, Folate, vitamin E, Niacin, niacinamide, Pantothenic Acid, Phosphorus, pyridoxine HCI, Vitamin B6, vitamin B2, Thiamin, sucralose, vitamin B12, vitamin B62024-11-29 10:47:42
TransformHQ Meal Replacement Shake - 7 Servings Vanilla -- 10 ozTransformHQActive Lifestyle & Fitnessd-alpha tocopheryl succinate, D-calcium pantothenate, vitamin D3, Vitamin E, Folate, vitamin E, Niacin, niacinamide, Pantothenic Acid, pyridoxine HCI, Vitamin B6, vitamin B2, Thiamin, vitamin B1, sucralose, vitamin B12, vitamin B62024-11-29 10:47:42
Vitacost-Synergy Basic® Multivitamin -- 60 CapsulesVitacost-SynergyVitamins & Supplementsd-alpha tocopheryl succinate, Vitamin C, d-beta tocopherol, Biotin, dicalcium phosphate, Chromium, Coenzyme Q10, Vitamin E, d-delta tocopherol, Folate, Vitamin E, Iodine, Lutein, Manganese, Molybdenum, Niacin, Pantothenic Acid, Vitamin B6, Quercetin, Vitamin A, Riboflavin, Selenium, Thiamin, Alpha Lipoic Acid, Vitamin B12, Vitamin B6, phytonadione, Vitamin K, Zeaxanthin2024-11-29 10:47:42

Drug Classes (2)

ClassDescription
tocolA chromanol with a chroman-6-ol skeleton that is substituted at position 2 by a saturated or triply-unsaturated hydrocarbon chain consisting of three isoprenoid units.
hemisuccinateA succinate ester in which only one of the carboxy groups of succinic acid has been esterified.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (30)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency24.82683.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency27.61180.006038.004119,952.5996AID1159521; AID1159523
SMAD family member 2Homo sapiens (human)Potency19.72060.173734.304761.8120AID1346859
USP1 protein, partialHomo sapiens (human)Potency35.48130.031637.5844354.8130AID504865
SMAD family member 3Homo sapiens (human)Potency19.72060.173734.304761.8120AID1346859
TDP1 proteinHomo sapiens (human)Potency29.85540.000811.382244.6684AID686978
AR proteinHomo sapiens (human)Potency27.68850.000221.22318,912.5098AID1259243; AID1259247; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency4.70480.000657.913322,387.1992AID1259377; AID1259378
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency21.31740.01237.983543.2770AID1645841
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency18.17520.000214.376460.0339AID720691; AID720692; AID720719
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency77.82050.003041.611522,387.1992AID1159553
retinoid X nuclear receptor alphaHomo sapiens (human)Potency2.78560.000817.505159.3239AID1159527
pregnane X nuclear receptorHomo sapiens (human)Potency19.54760.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency9.22550.000229.305416,493.5996AID743069; AID743075
GVesicular stomatitis virusPotency21.31740.01238.964839.8107AID1645842
cytochrome P450 2D6Homo sapiens (human)Potency37.90830.00108.379861.1304AID1645840
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency29.53420.001019.414170.9645AID743094; AID743191
activating transcription factor 6Homo sapiens (human)Potency35.83140.143427.612159.8106AID1159516; AID1159519
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency5.558019.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency24.82680.057821.109761.2679AID1159526
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency19.83650.000323.4451159.6830AID743065
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency17.42180.000627.21521,122.0200AID743219
Interferon betaHomo sapiens (human)Potency21.31740.00339.158239.8107AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency21.31740.01238.964839.8107AID1645842
Cellular tumor antigen p53Homo sapiens (human)Potency49.60340.002319.595674.0614AID651631
Spike glycoproteinSevere acute respiratory syndrome-related coronavirusPotency39.81070.009610.525035.4813AID1479145
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency21.31740.01238.964839.8107AID1645842
cytochrome P450 2C9, partialHomo sapiens (human)Potency21.31740.01238.964839.8107AID1645842
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)IC50 (µMol)32.41750.00053.49849.7600AID1416210; AID1416214; AID1416215; AID1416216
Glutathione S-transferase omega-1Homo sapiens (human)IC50 (µMol)4.00000.02801.60404.6000AID1384567
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (205)

Processvia Protein(s)Taxonomy
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
adaptive immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of T cell anergyHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
defense responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
detection of bacteriumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-12 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-6 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protection from natural killer cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
innate immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of dendritic cell differentiationHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class IbHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
positive regulation of JUN kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of endocytosisTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of vascular endothelial growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of intracellular protein transportTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cellular response to unfolded proteinTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of MAP kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of protein tyrosine kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of receptor catabolic processTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulumGlutathione S-transferase omega-1Homo sapiens (human)
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ionGlutathione S-transferase omega-1Homo sapiens (human)
positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ionGlutathione S-transferase omega-1Homo sapiens (human)
L-ascorbic acid metabolic processGlutathione S-transferase omega-1Homo sapiens (human)
xenobiotic catabolic processGlutathione S-transferase omega-1Homo sapiens (human)
negative regulation of ryanodine-sensitive calcium-release channel activityGlutathione S-transferase omega-1Homo sapiens (human)
positive regulation of ryanodine-sensitive calcium-release channel activityGlutathione S-transferase omega-1Homo sapiens (human)
cellular response to arsenic-containing substanceGlutathione S-transferase omega-1Homo sapiens (human)
cellular oxidant detoxificationGlutathione S-transferase omega-1Homo sapiens (human)
glutathione metabolic processGlutathione S-transferase omega-1Homo sapiens (human)
inositol phosphate metabolic processInositol hexakisphosphate kinase 1Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (61)

Processvia Protein(s)Taxonomy
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
peptide antigen bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein-folding chaperone bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
RNA bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
zinc ion bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
enzyme bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein phosphatase 2A bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
glutathione transferase activityGlutathione S-transferase omega-1Homo sapiens (human)
protein bindingGlutathione S-transferase omega-1Homo sapiens (human)
oxidoreductase activityGlutathione S-transferase omega-1Homo sapiens (human)
glutathione dehydrogenase (ascorbate) activityGlutathione S-transferase omega-1Homo sapiens (human)
methylarsonate reductase activityGlutathione S-transferase omega-1Homo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 1-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 3-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (42)

Processvia Protein(s)Taxonomy
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
Golgi membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
endoplasmic reticulumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cell surfaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
ER to Golgi transport vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
secretory granule membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phagocytic vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
early endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
recycling endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular exosomeHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
lumenal side of endoplasmic reticulum membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
MHC class I protein complexHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular spaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
external side of plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial matrixTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial cristaTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
sorting endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmic side of endoplasmic reticulum membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
virion membraneSpike glycoproteinSevere acute respiratory syndrome-related coronavirus
cytoplasmGlutathione S-transferase omega-1Homo sapiens (human)
cytosolGlutathione S-transferase omega-1Homo sapiens (human)
extracellular exosomeGlutathione S-transferase omega-1Homo sapiens (human)
cytoplasmGlutathione S-transferase omega-1Homo sapiens (human)
fibrillar centerInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytosolInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (60)

Assay IDTitleYearJournalArticle
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1064571Induction of superoxide radical generation in bovine NADH-respiring submitochondrial particles assessed as oxidation of CPH after 2 mins by ESR spectroscopy relative to control2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1064556Drug degradation in mouse N18TG2 cells assessed as alpha-TOH formation at 10 nmol after 24 hrs by HPLC analysis2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1416210Inhibition of PTP1B (1 to 298 residues) (unknown origin) using DifMUP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by fluorescence assay2017MedChemComm, Jun-01, Volume: 8, Issue:6
PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1B.
AID448013Inhibition of human SK-BR-3 cells adhesion to gelatinous matrix protein-coated surface after 60 mins by ELISA2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.
AID448010Inhibition of mouse 4T1 cells adhesion to gelatinous matrix protein-coated surface after 60 mins by ELISA2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.
AID1326576Cytotoxicity against hamster AG17-1 cells assessed as reduction in cell viability after 72 hrs by MTT assay2016European journal of medicinal chemistry, Oct-21, Volume: 122Antioxidant and antitumor activity of trolox, trolox succinate, and α-tocopheryl succinate conjugates with nitroxides.
AID1064569Induction of superoxide radical generation in bovine NADH-respiring submitochondrial particles assessed as oxidation of CPH at 900 uM after 2 mins by ESR spectroscopy in presence of superoxide dismutase relative to control2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1416217Reversible inhibition of PTP1B (1 to 298 residues) (unknown origin) using 10 fold excess DifMUP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by fluorescence assay2017MedChemComm, Jun-01, Volume: 8, Issue:6
PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1B.
AID1064561Induction of superoxide radical generation in bovine succinate-respiring submitochondrial particles assessed as oxidation of CPH at 900 uM after 2 mins by ESR spectroscopy in presence of rotenone2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID448640Effect on actin cytoskeletal structure in mouse 4T1 cells assessed as rapid loss of F-actin fiber-associated detachment from neighbouring cells at 10 uM after 4 hrs by immunocytochemistry2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.
AID1064560Induction of superoxide radical generation in mouse N18TG2 cells assessed as CMH oxidation at 200 uM after 2 hrs by ESR spectroscopy relative to control2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1326580Cytotoxicity against human CEM13 cells assessed as reduction in cell viability at 300 uM after 72 hrs by MTT assay2016European journal of medicinal chemistry, Oct-21, Volume: 122Antioxidant and antitumor activity of trolox, trolox succinate, and α-tocopheryl succinate conjugates with nitroxides.
AID448616Inhibition of mouse 4T1 cells adhesion to fibronectin at 5 to 100 uM after 60 mins by ELISA2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.
AID448618Inhibition of mouse 4T1 cells adhesion to vitronectin at 5 to 100 uM after 60 mins by ELISA2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.
AID1064572Inhibition of oxygen consumption in bovine succinate-respiring submitochondrial particles involving complexes 2,3,4 after 3 mins relative to control2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1416213Intrinsic redox activity of compound after 60 mins in presence of resazurin/DTT2017MedChemComm, Jun-01, Volume: 8, Issue:6
PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1B.
AID1326566Antioxidant activity in Salmonella typhimurium TA102 harboring hysG428 mutant assessed as inhibition of t-BuO2H-dependant mutant formation at 0.3 uM preincubated with compound followed by t-BuO2H addition after 48 hrs by Ames test2016European journal of medicinal chemistry, Oct-21, Volume: 122Antioxidant and antitumor activity of trolox, trolox succinate, and α-tocopheryl succinate conjugates with nitroxides.
AID448611Inhibition of human SK-BR-3 cells adhesion to gelatinous matrix protein-coated surface at 100 uM after 60 mins by ELISA2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.
AID1326572Cytotoxicity against human CEM13 cells assessed as reduction in cell viability after 72 hrs by MTT assay2016European journal of medicinal chemistry, Oct-21, Volume: 122Antioxidant and antitumor activity of trolox, trolox succinate, and α-tocopheryl succinate conjugates with nitroxides.
AID448624Inhibition of mouse 4T1 cells metastasis at 50 uM after 30 mins by Boyden chamber assay2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.
AID1064565Induction of superoxide radical generation in bovine succinate-respiring submitochondrial particles assessed as oxidation of CPH at 900 uM after 2 mins by ESR spectroscopy2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1064576Inhibition of bovine mitochondrial electron transport protein complex 1 NADH:dUQ oxidoreductase activity by spectrophotometry2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1064566Induction of superoxide radical generation in bovine NADH-respiring submitochondrial particles assessed as oxidation of CPH at 900 uM after 2 mins by ESR spectroscopy2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1326568Antioxidant activity in Salmonella typhimurium TA102 harboring hysG428 mutant assessed as inhibition of t-BuO2H-dependant mutant formation at 30 uM preincubated with compound followed by t-BuO2H addition after 48 hrs by Ames test2016European journal of medicinal chemistry, Oct-21, Volume: 122Antioxidant and antitumor activity of trolox, trolox succinate, and α-tocopheryl succinate conjugates with nitroxides.
AID1064558Drug degradation in denaturated rat liver homogenates assessed as compound recovery at 500 nmol after 4 hrs by HPLC analysis2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1064578Cytotoxicity against human HeLa cells at 100 to 200 uM by MTT assay2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1416216Competitive inhibition of PTP1B (1 to 298 residues) (unknown origin) using 60 uM DifMUP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by fluorescence assay2017MedChemComm, Jun-01, Volume: 8, Issue:6
PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1B.
AID1064575Inhibition of bovine mitochondrial electron transport protein complex 2 succinate:DCPIP oxidoreductase activity by spectrophotometry2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1326564Genotoxicity in Salmonella typhimurium TA102 harboring hysG428 mutant assessed as frequency of reversion from histidine auxotrophy to prototrophy at 30 mM after 48 hrs by Ames test (Rvb = 209 +/- 10 No _unit)2016European journal of medicinal chemistry, Oct-21, Volume: 122Antioxidant and antitumor activity of trolox, trolox succinate, and α-tocopheryl succinate conjugates with nitroxides.
AID1326571Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay2016European journal of medicinal chemistry, Oct-21, Volume: 122Antioxidant and antitumor activity of trolox, trolox succinate, and α-tocopheryl succinate conjugates with nitroxides.
AID1326567Antioxidant activity in Salmonella typhimurium TA102 harboring hysG428 mutant assessed as inhibition of t-BuO2H-dependant mutant formation at 3 uM preincubated with compound followed by t-BuO2H addition after 48 hrs by Ames test2016European journal of medicinal chemistry, Oct-21, Volume: 122Antioxidant and antitumor activity of trolox, trolox succinate, and α-tocopheryl succinate conjugates with nitroxides.
AID1064557Drug degradation in rat liver homogenates assessed as alpha-TOH formation at 500 nmol after 4 hrs by HPLC analysis2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID448011Inhibition of mouse 4T1 cells adhesion to gelatinous matrix protein-coated surface at 10 uM after 60 mins by ELISA2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.
AID1416215Competitive inhibition of PTP1B (1 to 298 residues) (unknown origin) using 30 uM DifMUP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by fluorescence assay2017MedChemComm, Jun-01, Volume: 8, Issue:6
PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1B.
AID448012Inhibition of human MCF7 cells adhesion to gelatinous matrix protein-coated surface after 60 mins by ELISA2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.
AID448638Induction of FAK degradation in mouse 4T1 cells at 5 uM after 1 hr by Western blotting2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.
AID448610Inhibition of human MCF7 cells adhesion to gelatinous matrix protein-coated surface at 100 uM after 60 mins by ELISA2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.
AID1064577Cytotoxicity against mouse N18TG2 cells at 6.25 to 100 uM by MTT assay2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1064573Inhibition of oxygen consumption in bovine NADH-respiring submitochondrial particles involving complexes 1,3,4 after 3 mins relative to control2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1326574Cytotoxicity against human MT4 cells assessed as reduction in cell viability after 72 hrs by MTT assay2016European journal of medicinal chemistry, Oct-21, Volume: 122Antioxidant and antitumor activity of trolox, trolox succinate, and α-tocopheryl succinate conjugates with nitroxides.
AID1416214Competitive inhibition of PTP1B (1 to 298 residues) (unknown origin) using 15 uM DifMUP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by fluorescence assay2017MedChemComm, Jun-01, Volume: 8, Issue:6
PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1B.
AID448617Inhibition of mouse 4T1 cells adhesion to laminin at 5 to 100 uM after 60 mins by ELISA2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.
AID1064559Drug degradation in rat liver homogenates at 500 nmol after 4 hrs by HPLC analysis2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1384567Inhibition of human GSTO1-1 by MMA (V) reductase assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Reviewing Hit Discovery Literature for Difficult Targets: Glutathione Transferase Omega-1 as an Example.
AID103204Compound was tested for antiproliferative activity against human breast cancer cell line MCF-7 in MTT assay1998Bioorganic & medicinal chemistry letters, Sep-22, Volume: 8, Issue:18
Design and synthesis of analogs of vitamin E: antiproliferative activity against human breast adenocarcinoma cells.
AID1326570Cytotoxicity against human RPMI8226 cells assessed as reduction in cell viability after 72 hrs by MTT assay2016European journal of medicinal chemistry, Oct-21, Volume: 122Antioxidant and antitumor activity of trolox, trolox succinate, and α-tocopheryl succinate conjugates with nitroxides.
AID1064574Inhibition of bovine mitochondrial electron transport protein complex 3 dUQH2:cytochrome c oxidoreductase activity by spectrophotometry2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1416211Effect on fluorescence read out during PTP1B enzymatic reaction compound treated post enzyme-substrate reaction and susequent H2O2-mediated enzyme deactivation2017MedChemComm, Jun-01, Volume: 8, Issue:6
PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1B.
AID1064568Induction of superoxide radical generation in bovine succinate-respiring submitochondrial particles assessed as oxidation of CPH at 900 uM after 2 mins by ESR spectroscopy in presence of superoxide dismutase relative to control2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1326561Genotoxicity in Escherichia coli PQ37 expressing lacZ gene assessed as ratio of inducible beta-galactosidase activity to alkaline phosphatase activity at 30 mM after 2 hrs by SOS-chromotest relative to control2016European journal of medicinal chemistry, Oct-21, Volume: 122Antioxidant and antitumor activity of trolox, trolox succinate, and α-tocopheryl succinate conjugates with nitroxides.
AID448615Inhibition of mouse 4T1 cells adhesion to collagen 4 at 5 to 100 uM after 60 mins by ELISA2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.
AID448633Effect on actin cytoskeletal structure in mouse 4T1 cells assessed as rapid dissolution of actin stress fibers at 50 uM after 4 hrs by immunocytochemistry2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.
AID1064570Induction of superoxide radical generation in bovine succinate-respiring submitochondrial particles assessed as oxidation of CPH after 2 mins by ESR spectroscopy relative to control2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
AID1326575Cytotoxicity against mouse LMTK cells assessed as reduction in cell viability after 72 hrs by MTT assay2016European journal of medicinal chemistry, Oct-21, Volume: 122Antioxidant and antitumor activity of trolox, trolox succinate, and α-tocopheryl succinate conjugates with nitroxides.
AID1326573Cytotoxicity against human U937 cells assessed as reduction in cell viability after 72 hrs by MTT assay2016European journal of medicinal chemistry, Oct-21, Volume: 122Antioxidant and antitumor activity of trolox, trolox succinate, and α-tocopheryl succinate conjugates with nitroxides.
AID1326569Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay2016European journal of medicinal chemistry, Oct-21, Volume: 122Antioxidant and antitumor activity of trolox, trolox succinate, and α-tocopheryl succinate conjugates with nitroxides.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's6 (66.67)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.64 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.43 (4.65)
Search Engine Demand Index63.39 (26.88)
Search Engine Supply Index3.72 (0.95)

This Compound (31.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]